24y
Pharmaceutical Technology on MSNESC 2024: Obesity drugs emerge as attractive tool for heart failure preventionExperts discuss the relationship between obesity and heart failure while referencing new clinical trial results.
Hosted on MSN1mon
Oruka Therapeutics inks exclusive license deal with ParagonParagon has agreed not to generate any new anti ... The company has initiated a Phase 1 study for its leading drug candidate, ORKA-001, and has plans to release interim data from this study ...
Erris Homes has secured a £5.4m funding package from Paragon Bank to support the next phase of a development in West Yorkshire. Phase II of Calder Mews in Halifax comprises 14 four-bedroom detached ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results